Please ensure Javascript is enabled for purposes of website accessibility

Why Mednax Stock Is Soaring Today

By Keith Speights - May 7, 2021 at 12:54PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are cheering the company's Q1 results.

What happened

Shares of Mednax (MD -2.64%) were soaring 16.3% higher at 11:56 a.m. EDT on Friday. The big gain came after the company announced its first-quarter results before the market opened.

So what

Mednax reported net revenue in the first quarter of $446.8 million. This result was well above the consensus Wall Street estimate of $424.1 million. The company announced adjusted earnings per share (EPS) from continuing operations of $0.24. This trounced the average analysts' estimate of $0.13.

Doctor talking with a patient

Image source: Getty Images.

COVID-19 continued to weigh on the medical services provider's performance in Q1. However, patient volumes weren't affected as much as in the fourth quarter of 2020.

Now what

Perhaps the biggest reason the healthcare stock is rising today is that investors are more confident about Mednax's prospects. Increased availability of COVID-19 vaccines could further reduce the negative impact of the pandemic on Mednax's business. The company also acquired two physician groups in the first quarter that will help boost its revenue.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

MEDNAX, Inc. Stock Quote
$20.26 (-2.64%) $0.55

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.